Your browser doesn't support javascript.
loading
Mid-Term Outcomes of Chimney Endovascular Aortic Aneurysm Repair: A Systematic Review and Meta-analysis.
Prapassaro, Tossapol; Teraa, Martin; Chinsakchai, Khamin; Hazenberg, Constantijn E V B; Hunnangkul, Saowalak; Moll, Frans L; van Herwaarden, Joost A.
Afiliação
  • Prapassaro T; Faculty of Medicine Siriraj Hospital, Division of Vascular Surgery, Department of Surgery, Mahidol University, Bangkok, Thailand. Electronic address: tossapol.vas@gmail.com.
  • Teraa M; Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Chinsakchai K; Faculty of Medicine Siriraj Hospital, Division of Vascular Surgery, Department of Surgery, Mahidol University, Bangkok, Thailand.
  • Hazenberg CEVB; Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Hunnangkul S; Faculty of Medicine Siriraj Hospital, Division of research group and research network, Mahidol University, Bangkok, Thailand.
  • Moll FL; Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
  • van Herwaarden JA; Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Ann Vasc Surg ; 79: 359-371, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34666145
BACKGROUND: To provide an overview of the literature on the mid-term outcomes of chimney EVAR (ChEVAR) for the treatment of juxtarenal abdominal aortic aneurysms (JAAA). METHODS: Different electronic databases were searched for published articles up to January 2020. The eligibility criteria were studies describing mid- or long-term outcomes of chimney EVAR (mean follow-up at least 1 year) for treatment of JAAA, including more than 10 cases, published in English, and with full text available. The outcomes measure were overall survival rate, target vessel patency, and freedom from reintervention at 3 years. Quality of the included studies was analyzed using the MINORS criteria. Pooled effect estimates were analyzed using random-effect models and heterogeneity was tested using I2 statistics. RESULTS: Thirteen articles met the inclusion criteria. The included studies described 1,019 patients. According to the quality assessment, methodological quality was moderate to poor. The pooled overall survival, freedom from reintervention, and target vessel patency at 3 year was 81.4 % (95%CI 73.8-87.9), 85.7% (95%CI 75.6-93.5), and 95.1% (95%CI 89.3-98.7) respectively. CONCLUSIONS: The results of this review show good to acceptable short and mid-term survival and good mid-term durability, which supports that ChEVAR as a suitable alternative in high-risk JAAA. However, proper patient selection for ChEVAR seems essential to attain good mid-term outcomes, and further large prospective and good quality studies are required to demonstrate its long-term results and enable conclusions on specific determinants for outcome.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aneurisma da Aorta Abdominal / Implante de Prótese Vascular / Procedimentos Endovasculares Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aneurisma da Aorta Abdominal / Implante de Prótese Vascular / Procedimentos Endovasculares Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article